Back
KalVista Pharmaceuticals 10K Form
Buy
51
KALV
KalVista Pharmaceuticals
Last Price:
9.11
Seasonality Move:
13.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KALV News And Ratings
See the #1 stock for the next 7 days that we like better than KALV
KALV Financial Statistics
Sales & Book Value
| Annual Sales: | $12.69M |
|---|---|
| Cash Flow: | $-39.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.10 |
| Price / Book: | 3.48 |
Profitability
| EPS (TTM): | -3.69000 |
|---|---|
| Net Income (TTM): | $-156.39M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
KalVista Pharmaceuticals Earnings Forecast
Key KalVista Pharmaceuticals Financial Ratios
- The Interest Expense is -4.79% of Operating Income.
- Per Share Earnings over the last 13 years have been positive in 4 years.
KalVista Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KALV |
| CUSIP: | 483497 |
| Website: | kalvista.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KALV Technical Analysis vs Fundamental Analysis
Buy
51
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy or a Sell?
-
KalVista Pharmaceuticals stock is rated a Buy
The current KalVista Pharmaceuticals [KALV] share price is $9.44. The Score for KALV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.